| Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy | |
| Zhao, Yinghao; Yang, Wei; Huang, Yuanyuan; Cui, Ranji; Li, Xiangyan; Li, Bingjin | |
| 刊名 | CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
 |
| 2018 | |
| 卷号 | 47期号:2 |
| 关键词 | Ctla-4 PD-1 Antibody ipilimumab Tremelimumab |
| ISSN号 | 1015-8987 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3535925 |
| 专题 | 吉林大学白求恩第一医院 |
| 推荐引用方式 GB/T 7714 | Zhao, Yinghao,Yang, Wei,Huang, Yuanyuan,et al. Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy[J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,2018,47(2). |
| APA | Zhao, Yinghao,Yang, Wei,Huang, Yuanyuan,Cui, Ranji,Li, Xiangyan,&Li, Bingjin.(2018).Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy.CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,47(2). |
| MLA | Zhao, Yinghao,et al."Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy".CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 47.2(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论